Autologous peripheral blood-derived CD34+ cell transplantation for acute kidney injury. - CD34+ cell Transplantation for acute kidney injury

Kidney Disease and Transplant Center, Shonan Kamakura General Hospital0 个研究点目标入组 9 人开始时间: 2018年3月26日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) shock vital. 2) respiratory failure who require mechanical ventilation. 3) pre-renal or post-renal acute renal failure 4) maintenance dialysis (HD or PD) 5) severely damaged cardiac function (EF<25%) 6) allergic reaction to GCSF, apheresis, or mouse anti CD34 antibody 7) past history of renal transplantation 8) malignancy or past history within past 5 years 9) diabetic proliferating retinopathy (B2 or more) 10) within 3 months from angina pectoris, myocardial infarction, or stroke 11) leukemia, myelo-proliferating disease, myelodyslastic syndrome, sickle cell anemia 12) autoimmune disease 13) liver cirrhosis 14) interstitial pneumonia 15) brain aneurysm which need treatment 16) white blood cell count <3000/uL or >15000/uL 17) platelet count <50000/uL 18) hemoglobin < 8 g/dL 19) AST or ALT >100 IU/L 20) albumin < 2g/dL 21) splenomegaly on CT imaging 22) pregnant woman 23) patients who have HBV, HCV, HIV, HTLV1 24) single kidney 25) patients who join other clinical study 26) patients who are judged not to be appropriate to participate in this study

发起方

Kidney Disease and Transplant Center, Shonan Kamakura General Hospital